As of 2026-09-10, the Relative Valuation of Gemini Therapeutics Inc (GMTX) is (27.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 USD, the upside of Gemini Therapeutics Inc based on Relative Valuation is -2113.4%.
The range of the Relative Valuation is (26.15) - (26.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.2x - 30.0x | 27.1x |
| Forward P/E multiples | 22.1x - 24.3x | 23.2x |
| Fair Price | (26.15) - (26.26) | (27.18) |
| Upside | -2037.3% - -2045.3% | -2113.4% |
| Date | P/E |